The GOC News


Dr. Amit Oza to Receive the GOC Presidential Medal

Words from the President

GOC has achieved significant recent successes, and a key goal of the President’s Message in the GOC Newsletter is to update you on the progress - from all of us for all of us. At the Communities of Practice (CoP) meeting focusing on the “No Woman Left Behind” BRCA Road Map (November 18, 2016) and recent developments in Endometrial and Cervical Cancer (November 19, 2016) there was a palpable momentum in the dynamics of the discussions. Position statements, care pathways, patient information education materials, grant proposals, economic models, we talk the talk and walk the walk. Perhaps what I find most striking about the work of our colleagues in the CoP working groups is how quickly they have moved us from understanding and consensus-building, to action and implementation, improving gynecologic cancer care. Position Statements on PARPi, BRCA Testing and Tumor Testing The consortium of stakeholders met together last September, and for the first time brought together medical oncologists, gynecologic oncologists, medical geneticists, laboratory molecular geneticists, genetic counsellors, pathologists and patient advocates, got to work discussing gaps, needs, and progress in genomic testing and targeted treatment of ovarian cancer. The November 2016 CoP meeting was the follow up meeting. First on the agenda was the review of the Position Statement on PARPi. Participants agreed on a new summarywritten for lay audiences, to includemore information about

Dr. Amit Oza, Senior Staff Physician and Professor of Medicine at the Princess Margaret Cancer Centre and the University of Toronto, will be presented with The Presidential Medal at this year’s AGM in Ottawa. The Presidential Medal is awarded by GOC’s nominating committee to persons or organizations who have significantly contributed to the field of gynecologic oncology in Canada and/or internationally. It is the highest recognition from our membership, our Board, and the Executive. We are pleased to recognize Dr. Oza’s immense contribution to the development of relevant clinical trials, his collaborative spirit in the advancement of treatment of gynecological cancers in Canada, as well as his global impact on the evaluation of novel therapeutic approaches. Join us in honouring our colleague and friend, Dr. Amit Oza at the presentation ceremony during the Gala dinner at the Fairmont Château Laurier, June 23 rd .



03 Use of PARP Inhibitors

05 38th AGMOttawa Highlights

07 GOC/APOGHealth Advocates

13 CoP BRCA Care

Made with